Author Correction: Reverse engineering synthetic antiviral amyloids

Emiel Michiels^#^{1

2}, Kenny Roose^#^{3

4}, Rodrigo Gallardo^{1

2}, Ladan Khodaparast^{1

2}, Laleh Khodaparast^{1

2}, Rob van der Kant^{1

2}, Maxime Siemons^{1

2

5}, Bert Houben^{1

2}, Meine Ramakers^{1

2}, Hannah Wilkinson^{1

2}, Patricia Guerreiro^{1

2}, Nikolaos Louros^{1

2}, Suzanne J F Kaptein⁶, Lorena Itatí Ibañez^{3

4}, Anouk Smet^{3

4}, Pieter Baatsen^{1

7}, Shu Liu⁸, Ina Vorberg^{8

9}, Guy Bormans⁵, Johan Neyts⁶, Xavier Saelens^{3

4}, Frederic Rousseau^{10

11}, Joost Schymkowitz^{12

13}

Affiliations

¹ VIB Center for Brain and Disease Research, Leuven, Belgium.
² Switch Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
³ VIB Center for Medical Biotechnology, Ghent, Belgium.
⁴ Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
⁵ Laboratory for Radiopharmacy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
⁶ Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
⁷ Electron Microscopy Platform of VIB Bio Imaging Core, KU Leuven, Leuven, Belgium.
⁸ German Center for Neurodegenerative Diseases (DZNE e.V.), Bonn, Germany.
⁹ Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany.
¹⁰ VIB Center for Brain and Disease Research, Leuven, Belgium. frederic.rousseau@kuleuven.vib.be.
¹¹ Switch Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium. frederic.rousseau@kuleuven.vib.be.
¹² VIB Center for Brain and Disease Research, Leuven, Belgium. joost.schymkowitz@kuleuven.vib.be.
¹³ Switch Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium. joost.schymkowitz@kuleuven.vib.be.

^# Contributed equally.

Published Erratum

Emiel Michiels et al. Nat Commun. 2023.

. 2023 Jun 13;14(1):3492.

doi: 10.1038/s41467-023-39293-9.

¹ VIB Center for Brain and Disease Research, Leuven, Belgium.
² Switch Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
³ VIB Center for Medical Biotechnology, Ghent, Belgium.
⁴ Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
⁵ Laboratory for Radiopharmacy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
⁶ Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
⁷ Electron Microscopy Platform of VIB Bio Imaging Core, KU Leuven, Leuven, Belgium.
⁸ German Center for Neurodegenerative Diseases (DZNE e.V.), Bonn, Germany.
⁹ Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany.
¹⁰ VIB Center for Brain and Disease Research, Leuven, Belgium. frederic.rousseau@kuleuven.vib.be.
¹¹ Switch Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium. frederic.rousseau@kuleuven.vib.be.
¹² VIB Center for Brain and Disease Research, Leuven, Belgium. joost.schymkowitz@kuleuven.vib.be.
¹³ Switch Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium. joost.schymkowitz@kuleuven.vib.be.

^# Contributed equally.

No abstract available

Erratum for

Reverse engineering synthetic antiviral amyloids.
Michiels E, Roose K, Gallardo R, Khodaparast L, Khodaparast L, van der Kant R, Siemons M, Houben B, Ramakers M, Wilkinson H, Guerreiro P, Louros N, Kaptein SJF, Ibañez LI, Smet A, Baatsen P, Liu S, Vorberg I, Bormans G, Neyts J, Saelens X, Rousseau F, Schymkowitz J. Michiels E, et al. Nat Commun. 2020 Jun 5;11(1):2832. doi: 10.1038/s41467-020-16721-8. Nat Commun. 2020. PMID: 32504029 Free PMC article.